This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jan;126(1):125-126.

doi: 10.1016/j.ophtha.2018.08.024.

The Lowdown on Low-Concentration Atropine for Myopia Progression

Padmaja Sankaridurg¹, Huy D M Tran²

Affiliations

PMID: 30577908
DOI: 10.1016/j.ophtha.2018.08.024

Editorial

The Lowdown on Low-Concentration Atropine for Myopia Progression

Padmaja Sankaridurg et al. Ophthalmology. 2019 Jan.

. 2019 Jan;126(1):125-126.

doi: 10.1016/j.ophtha.2018.08.024.

Authors

Padmaja Sankaridurg¹, Huy D M Tran²

Affiliations

¹ Sydney, Australia. Electronic address: p.sankaridurg@brienholdenvision.org.
² Sydney, Australia; Ho Chi Minh City, Vietnam.

PMID: 30577908
DOI: 10.1016/j.ophtha.2018.08.024

No abstract available

PubMed Disclaimer

Comment on

Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Yam JC, et al. Ophthalmology. 2019 Jan;126(1):113-124. doi: 10.1016/j.ophtha.2018.05.029. Epub 2018 Jul 6. Ophthalmology. 2019. PMID: 30514630 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science